Product: Human medicines

• Q&A: How is pharmaceutical marketing regulated in Finland? Requirements and compliance issues

  15.04.2026

  

• How do post-marketing drug safety practices differ between Japan, the US, and the EU

  07.04.2026

  

• Planning a marketing authorisation transfer in the Baltic countries: key considerations

  17.03.2026

  

• Maintaining a marketing authorisation in the EU: MAH responsibilities after approval

  11.03.2026

  

• What are the MAH’s post-authorisation pharmacovigilance responsibilities

  10.03.2026

  

• What does it take to enter the EU pharmaceutical market? Regulatory, supply chain and market access realities explained

  27.02.2026

  

• Major pharmacovigilance reform: EU Regulation 2025/1466 sets new standards for MAHs

  12.02.2026

  

• Looking for a reliable medical information service provider?

  16.01.2026

  

• The new EC variation guideline applies 15 January 2026

  14.01.2026